NeuroSense Therapeutics NRSN
NASDAQ NRSN
$2.56 +0.17 (+7.11%)
At close: Oct 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Receivables (2020 - 2023)

Updated

NeuroSense Therapeutics' Receivables came in at $472,000 for Q4 2023, up 30.4% from $362,000 a year earlier.

Analysis

NeuroSense Therapeutics (NRSN) Receivables (2020 - 2023) Analysis & Trends

Going back to Q4 2020, NeuroSense Therapeutics' Receivables data covers 4 quarters.

  • Receivables carries a three-year compound annual growth rate of 98.9% (FY2020 to FY2023).
  • Going back by year, Receivables was $510,000 in FY2022 (-17.7%), $620,000 in FY2021 (+933.3%) and $60,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 13.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 12.49 Bn
10 NeuroSense Therapeutics 3.19 Mn -1.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 472,000.00
Dec 31, 2022 362,000.00
Dec 31, 2021 386,000.00
Dec 31, 2020 60,000.00
API Access

NeuroSense Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=NRSN&period=max&api_key=YOUR_API_KEY